CRISPR/Cas9によるインビボゲノム編集
Keiichiro Suzuki1, Yuji Tsunekawa2, Reyna Hernandez-Benitez1,3
1Gene Expression Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd, La Jolla, California 92037, USA.
Nature
|November 17, 2016
まとめ
科学者たちはホモロジー・インデペンデント・ターゲティング・インテグレーション (HITI) と呼ばれる新しい遺伝子編集方法を開発しました このCRISPR/Cas9ベースのツールは様々な細胞に効率的なDNA統合を可能にし 遺伝的疾患の遺伝子治療を進めています
科学分野:
- 生物医学研究
- 遺伝子療法
- 遺伝学
背景:
- エンジニアリングされた核酸は 生物医学研究における臨床応用の可能性を 提供しています
- 現在のイン・ビボ標的型トランスゲン統合方法は,特に分裂しない細胞では非効率であり,遺伝疾患の研究と治療の開発を妨げています.
研究 の 目的:
- 細胞分裂と非分裂の両方における標的DNA統合のための新しい効率的な方法を開発する.
- 臨床前モデルで新しい方法の治療的可能性を実証する.
主な方法:
- CRISPR/Cas9技術に基づくホモロジー・インデペンデント・ターゲッテッド・インテグレーション (HITI) 戦略の開発
- 生後哺乳類のニューロンを含むDNAノックインに対するHITIの有効性を試験する.
- 視力機能の改善のための治療的可能性を評価するために,HITIのラットモデルでの評価.
主要な成果:
- HITI戦略は,分裂する細胞と分裂しない細胞の両方で堅固なDNAノックインを可能にします.
- 産後哺乳類のニューロンにHITIをインビボで成功させた.
- HITIを使用したラットモデルで視覚機能の改善が実証され,治療効果が示されました.
結論:
- HITI方法は,既存の技術の限界を克服し,標的型DNA統合のための堅牢で効率的なアプローチを提供します.
- この戦略は基本的な生物学的研究と 遺伝的疾患の標的型遺伝子治療の開発に 新たな可能性をもたらします
- HITIは,網膜変性における臨床前モデルの有効性を示すように,治療手段として有望である.
関連する概念動画
01:28CRISPR/Cas9 Genome Editing
2.3K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.3K
02:31Homologous Recombination
64.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
64.9K
01:59CRISPR
58.6K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.6K
02:53Conservative Site-specific Recombination and Phase Variation
7.2K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
7.2K
02:53CRISPR and crRNAs
19.4K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.4K